| | | |
rajesh@azicopharma.com
 
 
 
 
 
 

Just the right partner for your product development, Azico objective is:

To develop APIs close to approval dates of brands so as to work at R&D stage with generic companies fairly early so that the relationship is to nurtured.

To develop niche small volume APIs, which could be of no commercial interest for large API manufacturing companies for small volume products like Nicergoline , Avanafil etc at competitive price !

To develop IP strategy for molecules which are yet to be approved and file process patents, polymorph / salt patents encompassing the product which would provide a unique platform for the company to partner with generic companies.

To develop APIs where there are no active DMFs operating in US or EU.

Contracts for customer exclusivity base development of APIs are welcomed. Customers enquiries / proposal are invited for exploring such opportunities for mutual benefit.
 

DMFs & COS / CEPs

  • 2 DMFs & COS are expected to be filed in 2nd half of 2013.
  • 3 DMFs & COS are planned to file in 1st half of 2014.
 
Products
Pipeline Products

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. However, the final responsibility, with respect to third party patents rights in a specific country,  lies exclusively with user.  

 
 
Home | About Us | Advantage Azico | Products | Quality & Regulatory Systems | R & D | Manufacturing | Environment & Safety | Employee Login | Contact Us
 Copyrights Reserved 2012.     Designed by